Thank you to everyone who contributed and participated in CT-Cann2023. The Congress was a great success and we are already working on CT-Cann2024. Details coming soon…
It is a great pleasure to warmly invite you to participate in the upcoming 2nd International Congress on Clinical Trials on Cannabis (CT-Cann2023), which will take place 15-16 February 2023 in London, UK.
It has been a long and eventful nearly 3 years since CT-Cann2019, and our hopes of meeting again had to be put on hold. It is a joy that we are finally able to hold CT-Cann2023 while adhering to health guidance that will ensure a safe event for all of us.
Despite the understandable focus on COVID related research in the last two plus years, the therapeutic implications of cannabinoids has also remained an intense interest of study yielding new discoveries and a deeper understanding…
Meet our Speakers
McLean Hospital Cognitive and Clinical Neuroimaging Core and Marijuana Investigations for Neuroscientific Discovery (MIND), and Dept of Psychiatry at Harvard Medical School, USA
Medical Cannabis Clinicians Society and UK Cannabis Industry Council, UK
Imperial College Healthcare NHS Trust, UK, President of the British Pain Society
Centre for Pain Research, University of Galway, Ireland
Chief Research Office, Drug Science, UK
Phytoreceptors ApS, Denmark
Pain Relief Unit, Hadassah Hebrew University Medical Center, Israel
We look forward to hearing from you.